ESLA
Estrella Immunopharma, Inc. - Common Stock (ESLA)
$44
About Estrella Immunopharma, Inc. - Common Stock (ESLA)
Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.
Details
Daily high
$0.48
Daily low
$0.40
Price at open
--
52 Week High
$3.01
52 Week Low
$0.24
Market cap
18.2M
Dividend yield
-
Volume
1
Avg. volume
5.7M
P/E ratio
-1.65
Estrella Immunopharma, Inc. - Common Stock News
Details
Daily high
$0.48
Daily low
$0.40
Price at open
--
52 Week High
$3.01
52 Week Low
$0.24
Market cap
18.2M
Dividend yield
-
Volume
1
Avg. volume
5.7M
P/E ratio
-1.65